MYC and sarcoma: Here we show, in contrast to the osteogenic sarcoma model, that re-activating c-Myc in islet β-cell tumours restores the oncogenic properties of c-Myc, rapidly re-initiating β-cell proliferation, loss of differentiation, loss of E-cadherin, local invasion and angiogenesis.